Avalo Therapeutics, Inc. (AVTX)
Latest AVTX Insider Trades
About Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
- WAYNE, PA
- 33
- 2015
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 84,163 | $1.68M |
| Grant or award | 10 | 172,454 | |
| Option exercise | 18 | 161,270 |
AVTX Insider Transactions (Form 4)
462 Form 4 filings on record, the earliest from Nov 14, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gilla Kaplan - Director | Option exercise | Common Stock | 3,167 |
Recent AVTX Form 8-K Filings
5Recent AVTX Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| CHRISTOPHER RYAN SULLIVAN | Officer | 31,031 | $622K | View on EDGAR | |
| CHRISTOPHER RYAN SULLIVAN | Officer |
AVTX Insider Trading - FAQ
What is the latest insider trade for AVTX?
Avalo Therapeutics, Inc. (AVTX) had 21 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for AVTX runs to 62 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AVTX stock?
No insider purchases of AVTX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling AVTX stock?
9 insider sales of AVTX were filed in the last 90 days, totaling $1.68M.
Where can I see AVTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks AVTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AVTX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add AVTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Christopher Ryan Sullivan view on EDGAR
- - Mittie Doyle view on EDGAR
- - Jennifer Riley view on EDGAR
- - Mittie Doyle view on EDGAR
- - Mittie Doyle view on EDGAR
- - Mittie Doyle view on EDGAR
- - Ron M. Philip view on EDGAR
- - Kevin Robert Lind view on EDGAR
- - Rita Jain view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where AVTX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track AVTX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
